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Summary 
The polyclonal stimulation of T cells by bacterial  superantigens is involved in the pathogenesis 
of the toxic shock syndrome in certain staphylococcal and streptococcal infections. Here we describe 
the onset and kinetics of superantigen-induced cytokine production in situ in spleens of normal 
BALB/c  mice monitored at the level of cytokine mRNA expression by in situ hybridization. 
Messenger RNAs for interleukin 2 (IL-2),  interferon %  and tumor necrosis factors (TNF) c~ 
and/3 were not expressed  at detectable levels in spleens of unstimulated animals but became 
visible already 30 min after intraperitoneal application of 50/~g staphylococcal enterotoxin B. 
All mRNA levels showed peak expression approximately 3 h after injection and a slow decrease 
up to 24 h after injection. Expression of the mRNAs was restricted to the T  cell-dependent 
area of the periarteriolar lymphatic sheets of the spleen. Interestingly, TNF-oe mRNA showed 
a biphasic response, the early appearing mRNA had the same localization as the other mRNAs, 
whereas after 3 h TNF-ol mRNA showed a broader distribution indicating a second cell population 
producing TNF-o~. The expression of IL-2 and TNF proteins in the serum increased in parallel 
to the observed mRNA changes with a slight delay. The presence of macrophages was not required 
for the expression of the cytokine mRNAs in the spleen as the expression  was unchanged in 
macropbage-depleted mice. Only the second phase of TNF-c~ mRNA expression was abrogated 
in such animals. The expression of all mRNAs was completely suppressed by prior administration 
of cyclosporin A. These data show that nonphagocytic  cells are the essential superantigen-presenting 
cells in vivo and indicate that at least part of the pathogenetic TNF-ol is T  cell derived. 
n in situ analysis of a T cell response should provide in- 
formation on the distribution of induced events in the 
affected organs and on the kinetics of the response.  In con- 
trast, in vitro experiments allow only a vague approximation 
of the kinetics of an immune response and do not give much 
information on the significance of cellular  interactions for 
the events in vivo. It is therefore surprising that such anal- 
yses in vivo have only rarely been performed so far, possibly 
because of the usually low frequency of responding cells in 
antigen-specific immune reactions. 
The study of a superantigen response has the advantage 
that a superantigen activates  a large fraction of T  cells by 
a mechanism closely resembling antigen recognition. Super- 
antigens, such as the staphylococcal enterotoxins, cross-link 
variable parts of the TCR with MHC class II antigens on 
APCs. Consequences of this massive T cell activation are the 
transient expansion of the stimulated T cell subset followed 
by death and development of anergy in these cells, and even- 
tually shocklike symptoms due to a burstlike expression of 
different cytokines (1,  2). 
TNF has been reported to play a critical role in the devel- 
opment of superantigen-induced toxic shock because an an- 
tibody against TNF has a protective effect (3). The cellular 
source of TNF and the pattern of cytokine secretion in vivo 
have not yet been characterized.  In vitro studies have demon- 
strated that staphylococcal enterotoxins can induce TNF-cr 
from purified macrophages, probably by binding to their MHC 
class II molecules (4, 5). Studies with mutant superantigens 
have indicated that class II binding alone was insufficient to 
cause toxicity in mice (6, 7). A current model therefore postu- 
lates that TNF is produced by macrophages but that T cells 
are required to induce an enhanced TNF production by mac- 
rophages (7), most likely via released IFN-3, (7). Although 
T  cells are able to produce TNF-o~ after  stimulation with 
superantigens (8), they have not been implicated as a major 
source of this cytokine. 
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sponse in the spleen to a single injection of the staphylococcal 
enterotoxin B (SEB) t, a prototypic superantigen activating 
in mice all T cells bearing VB8 TCR (9), by in situ hybrid- 
ization for mRNAs. We demonstrate an extremely rapid ac- 
cumulation of cytokine mRNA in situ and describe evidence 
that at least part of the TNF is T  cell derived. 
Materials  and Methods 
Reagents.  SEB was produced as a recombinant protein in Staph- 
ylococcus aureus SK291 (10), and was purified to apparent homo- 
geneity as described previously (11). LPS from Salmonella typkimu- 
riura was purchased from Sigma Chemical Co. (Munich, FP,  G). 
Cydosporin A (CyA), a gift of Sandoz Inc. (Basel, Switzerland), 
was dissolved in olive oil. The anti-VB8 mAb F23.1 and the an- 
timacrophage mAb F4/80 (12) were obtained from the American 
Type Culture Collection (Rockville, MD). They were purified on 
protein G-Sepharose columns and conjugated with FITC according 
to standard procedures. Unless indicated, all chemicals were from 
Sigma, and all molecular biology reagents from Boehringer Mann- 
helm (Mannheim, FRG). 
DNA Probes and In  Vitro Transc@tion.  Four cytokine cDNA 
probes were used as RNA probes. The IL-2 probe was a 504-bp 
HindlII-EcoRI fragment of  exon 4 cloned into pGEM (gift of Dr. 
A. Schimpl, University of Wf]rzburg, FRG); the IFN-'y probe was 
a 643-bp cDNA fragment cloned into pSP65 (gift of Dr. E. Rfide, 
University of  Mainz, FRG); the TNF-c~ probe was a 470-bp cDNA 
fragment cloned into pGEM3(-) (gift of Dr. D. M~nnel, Univer- 
sity of Regensburg, FRG); and the TNF-B probe was a 700-bp 
BstXI-XbaI fragment of routine TNF-B cDNA (gift of Dr. N. 
Puddle, Yale University Medical School, New Haven, CT) cloned 
into pGEM7Zf(+). The plasmids were linearized with the appro- 
priate restriction enzymes and transcribed to antisense or sense 
cRNA using SP6 or T7 polymerases  as appropriate in the presence 
of ~sS-UTP (New England Nuclear, Dreieich, FRG). With the ex- 
ception of IFN-% all experiments were performed with both an- 
tisense and sense RNA probes. 
All labeled  cRNAs were purified  over Nick columns (Pharmacia, 
Freiburg, FRG) and diluted in hybridization buffer (100 mM "iris, 
pH 7.5, 600 mM NaCI,  1 mM EDTA, 0.5 mg/ml t-RNA, 0.1 
mg/ml sonicated salmon sperm DNA, lx  Denhardt's solution, 
10% dextran sulfate, 50% formamide) to 50,000 cpm//d, cRNA 
was stored for not longer than 2 wk at  -75~ 
Treatment of Mice.  BALB/c  mice were injected intraperitoneally 
with 50/zg of SEB or 5/~g of LPS. Higher and lower doses of 
SEB have been shown to lead to strong T cell stimulation in vivo 
(3,  13). This dose has been sera and spleens were removed after 
0.5, 1, 2, 3, 4, 9, 24, or 48 h. Organs were immediately embedded 
in Tissue  Tek (Miles Laboratories,  Elkhart, IN) and frozen in -30~ 
cold isopentan. Tissues  were stored at -75~  until 16-/~m cryostat 
sections were cut  and stored at  -75~  CyA was injected in- 
traperitoneally at 50 mg/kg 4 h before the enterotoxin. For deple- 
tion of  macrophages  from sFleens,  mice were injected intravenously 
with 200/zl of liposomes containing dichloromethylene diphos- 
phonate (ChMDP)  as described (14). This treatment  leads to a 
complete disappearance of phagocytic cells in spleen and liver after 
48 h (14). 
Bioassaysfor IL-2 and TNF-cr.  Ib2 in the serum was measured 
1 Abbreviations used in this paper: C12MDP, chloromethylendiphosphonate; 
CyA, cyciosporin  A; PALS, periarteriolar lymphatic  sheet; SEB, staphy- 
lococcal enterotoxin B. 
by a CTLL test. CTLL2 cells  were cultured in a 96-well plate with 
2,500 cells per well in Iscove's medium supplemented with 5% 
FCS, 0.1% gentamicin, 1% glutamine, and 0.1% 2-ME. Serum 
samples were used at a dilution of 1:100 and measured in tripli- 
cates. After 24 h, cells were pulsed with [3H]thymidine  overnight, 
harvested, and incorporation was measured by liquid scintillation 
counting. TNF-oL  was measured using its cytotoxic effect on ac- 
tinomycin D-pretreated Wehi 164 cells. The cells were incubated 
with dilutions of  serum, and after overnight incubation, viable cells 
were determined by incubation with methylthiazol-tetrazolium 
(Sigma Chemical Co.). 
In Situ Hybridization.  In situ hybridization was preformed with 
small modifications  as described  by Sch~fer  et al. (15). Serial 16-/~m 
cryostat sections were fixed  in 4% paraformaldehyde  in PBS at 4~ 
for 1 h, washed  three times in PBS, pretreated  by 0.4% Triton X-100 
in PBS for 5 rain, and acetylated for 10 min in 0.1 M triethanola- 
mine, pH 8.0, with 0.25% acetic anhydride. Tissues were washed 
in 2 x SSC, dehydrated in ethanol, and stored at  - 20~  until hy- 
bridization. Hybridization with cRNA, prepared by in vitro tran- 
scription, was performed by incubation of 35/~1 of cRNA on tissue 
sections for 16-18 h at 52~  in a moist chamber. Sections were 
washed in 2 x SSC and lx SSC for 10 min each and single-stranded 
RNA was digested by 10/zg/ml RNAse and 1 U/ml T1 RNase 
(Boehringer Mannheim) in Tris-EDTA, pH 8.0, and 150 mM NaC1 
at 37~  for I h. Afterwards, sections were desalted  by passing them 
through lx SSC, 0.5 x SSC, 0.2 x SSC for 10 min each, and washed 
in 0.2x SSC at 60~  for 1 h. The tissue sections were then washed 
in H20 for 10 min, dehydrated by ethanol,  and air-dried. Au- 
toradiograms were taken by exposing the sections to an autoradi- 
ography film (Hy]x~film-MP; Amersham, Dreieich, FRG)  for 
1-3 d. Autoradiograms were digitized and evaluated with an M4 
MCID image analysis system (Imaging Res. Inc., St. Catherines, 
ON, Canada). Sections  were then coated with NBT film emulsion 
(Eastman Kodak, Rochester, NY). Coated tissues were developed 
and fixed after 15-25 d (D19 developer, Eastman Kodak) and coun- 
terstained  with hematoxylin-eosin  as described. Although not shown 
in the figures, sense  probes were used in each experiment and never 
gave any signal above background. 
Results 
Kinetics and Distribution  of Cytokine  mRNA  in the Spleens 
of  SEB-treated Mice  In spleens of untreated or mock-injected 
mice,  the expression of mRNA coding for IL-2,  IFN-% 
TNF-ot, and TNF-~ was below detection level (Figs.  1, A 
and F and 2, A and F). Intraperitoneal injection of SEB gener- 
ated a rapid appearance of mRNAs for these cytokines. IL-2 
mRNA was detectable as early as 30 min after injection by 
x-ray film and also in emulsion-coated autoradiograms (not 
shown). Levels of IL-2 mRNA were maximal 3-4 h  after 
injection, decreased  thereafter, and completely disappeared 
48 h after injection (Fig.  1, G and K). Similarly, mRNA for 
IFN-3~ could be detected 30 min after injection and there- 
after increased  to a peak period lasting from 3 to 9 h (Fig. 
1,  B  and C).  This mRNA had a  slower decay than IL-2 
mRNA, but had also disappeared  within 48 h  (Fig.  1 E). 
The localization of both mRNAs was mainly restricted 
to the T  cell areas. Both IFN-~/and IL-2 mRNA showed 
a region-specific  distribution pattern. Under dark-field illu- 
mination, numerous positively labeled cells with medium to 
very high density of grains were concentrated around nonla- 
1532  Superantigen-induced  Cytokines Figure  1.  Kinetics and distribu- 
tion of SEB-induced IL.2 mRNA 
and IFN-  7  mRNA in the spleen. 
Serial sections (16/~m) of spleens 
were hybridized with  3sS-labeled 
cRNA probes for Ib2 (A-E) and 
IFNw (F-K) and emulsion-coated 
autoradiograms were evaluated. (.4 
and F) Spleens of untreated mice; 
(B and G) 3 h after injection; (C and 
H) 9 h; (D and/) 24 h; (E and K) 
48 h.  x15. 
1533  Bette et al. Figure  2.  Kinetics and distribu- 
tion  of SEB-induced TNF-~ and 
TNI~ mRNA in the spleen. Serial 
sections adjacent to those shown in 
Fig. 1 were hybridized  with probes 
for  TNF-ot (A-E)  and  TNF-B 
(F-K).  (A and F) Spleens of un- 
treated mice; (B and G) 30 rain after 
injection; (C and H) 1 h; (D and 
/)2h;  (EandK) 4h.  x15. 
Figure  3.  Localization  of cytokine mRNA in spleens of SEB-injected mice. Spleen sections were hybridized  with probes for I1.,2 mRNA (A), IFN-'~ 
mRNA (B), and TNF-cr mRNA (C and D), coated with film emulsion, and after exposure and development, counterstained with hematoxylin-eosin. 
The spleens were taken at different time points after SEB injection (A: 3 h, B: 9 h, C: 0.5 h, D: 3 h). Magnification: x300. (RP) Red pulp; (A) 
arteriole; (G) germinal center. beled, oval-shaped areas. These regions, which appear dark 
in the figures, were identified as B cell follicles, because they 
were specifically stained with antisera against mouse Ig in 
adjacent serial sections (data not shown). Furthermore, bright- 
field analysis of counterstained spleen sections from animals 
expressing peak cytokine mRNA levels were analyzed and 
compared to the known architecture  of mouse spleen (16, 
17). They revealed the concentration of strongly positive la- 
beled cells for both mRNAs in the T cell areas surrounding 
the B cell follicles, the periarteriolar lymphatic sheaths (PALS) 
(Fig. 3, A and B). A few sigual-bearing cells were also present 
in non-PALS region. 
Similar kinetics were found with TNF-o~ mRNA (Fig. 
2, A-E). This cytokine mRNA was strongly expressed 30 
rain after SEB injection and completely disappeared within 
48 h. Interestingly, the localization of TNF-ot mRNA changed 
over the observation  period. The early appearing  TNF-c~ 
mRNA had the same periarteriolar localization as the mRNA 
for IL-2 and IFN-% After 3-4 h, however, staining of TNF-cr 
mRNA showed a broader distribution, indicating that addi- 
tional cells had been induced to express this mRNA (Fig. 
2, D and E). In stained sections, the early TNF-c~ mRNA 
was restricted to the PALS (Fig. 3 C), whereas after 3 h, strong 
signals were found in the red pulp as well (Fig. 3 D). In con- 
trast,  TNF-/3 mRNA was first detectable after 1 h and had 
already  nearly completely disappeared  after  4  h  without 
changing its distribution pattern restricted to the PALS (Fig. 
2, F-K). 
The time course of IL-2 and TNF-ol bioactivity in the serum 
correlated with these findings. Both cytokines were detect- 
able 1 h after injection, showed a maximum after 2 h (TNF-ot) 
or 3 h (IL-2),  and thereafter  decreased rapidly  (Fig. 4). 
Effect of Macrophage Depletion on Splenic Cytokine Response 
to SER  To examine if macrophages play an important role 
in the cytokine response to SEB, we depleted phagocytic ceils 
by intravenous  injection of liposomes containing C12MDP. 
This regimen has been shown to deplete macrophages com- 
pletely from spleen and liver (14). 2 d after liposome injec- 
tion, F4/80-positive  cells could neither be detected by im- 
munofluorescence  in spleen tissue sections (Fig.  5 E), nor 
in suspensions of spleen cells by flow cytometry (data not 
shown). It is noteworthy that the spatial and temporal pat- 
tern of mRNA production in the spleen for IL-2,  IFN-'y, 
and TNF-13 after SEB injection was essentially unchanged. 
This is shown for IL-2 mRNA in Fig. 5, B and F, but the 
same findings were made with IFN-y and TNF-B mRNAs 
(data not shown). In contrast, the pattern of TNF-cx mRNA 
expression was different: the shift to a broader distribution, 
seen in normal mice after  3-4  h,  did not occur (Fig.  6). 
Moreover, after i.p. injection of LPS into macrophage-depleted 
mice, TNF-c~ mRNA was produced at strongly reduced levels 
and showed a more restricted,  clustered localization  (Fig. 5 
/3). Examination of counterstained sections by light micros- 
copy showed that the signals were located in the T call areas 
(data not shown). 
Sensitivity of Cytobine Production to CyA.  CyA that is a 
potent inhibitor of T cell activation has been shown to pro- 
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Figure 4.  Detection of IL2 and TNF bioactivity in mouse serum after 
SEB injection. Cytokines were assayed in serial dilutions of sera in bioas- 
says.  Data  are the mean concentrations in three animals. 
tect mice from staphylococcal  enterotoxin-induced lethal shock 
(3). We therefore investigated the effect of this drug on the 
expression of the four cytokine mRNAs. CyA treatment com- 
pletely abrogated the appearance of all four cytokine mRNAs 
in the spleen demonstrating their T cell-derived and activation- 
dependent expression (data not shown). 
Discussion 
The potent T cell stimulatory activity of staphylococcal 
and streptococcal superantigens is an important pathogenidty 
factor in the infections with these bacteria. In particular the 
stimulation of a large fraction of T cells has been implicated 
as responsible for the shocklike syndrome occurring during 
certain infections with S. aureus and Streptococcus pyogenes or 
after injection of a superantigen  into experimental  animals 
(3,  18). A  systemic  lymphokine secretion  as  the  prime 
pathogenetic mechanism has been proposed.  This notion is 
supported by the observations that experimental or therapeutic 
application of anti-CD3 mAb can induce a shock syndrome 
in mice and humans (19). 
Although the molecular and cellular interactions  during 
T cell stimulation in vitro by superantigens are well known, 
the early events after introduction of a superantigen into the 
organism are poorly characterized. In this study, we have ana- 
lyzed the localization and the kinetics of the cytokine burst 
after injection of a toxic superantigen at the level  of the cytokine 
mRNA. We found a rapid accumulation of mRNA for IL-2, 
IFN-% and TNF-c~ in the spleen, with significant levels of 
these cytokine mRNAs already after 30 rain, whereas after 
in vitro stimulation accumulation of IL-2, mRNA has been 
described to require 3-6 h and to peak after  17-24 h (20, 
21). Moreover, in vivo mRNAs were expressed only for a 
short period of time, in contrast to the in vitro findings 
showing that mRNAs are present for up to 72 h after stimu- 
lation (22-24).  TNF-B mRNA, for example, is present  at 
maximal levels for at least 48 h after in vitro stimulation (22), 
1536  Superantigen-induced Cytokines Figure  5.  Effect  of macrophage depletion on expression of cytokine mRNAs after $EB stimuhtion.  Sections of spleens from normal (A-D) and 
macrophage depleted mice (E-H) were stained for the expression of the F4/80 antigen in immunofluorescence  (A and E) and for the expression of 
II.-2 mKNA (B and F), and TNF-a mRNA (C and G) after injection of 50 ~g SEB or for TNF-a mRNA 3 h after injection of 5 ~g LPS (D and 
H). Hybridized autoradiograms were analyzed with  an image analyzer, the color code indicating the intensity of labeling is introduced into panel 
B.  ￿  (A and E). 
1537  Bette et al. Figure 6.  Differential  distribution  of TNF-t~ mILNA  in normal  and 
macrophage-depleted  spleens  3 h after SEB stimulation.  Normal  (A) and 
macrophage-depleted  mice  (B) were  injected  with 50 ttg of  SEll, and spleens 
taken  after  3 h were  hybridized  with a TNF-c~  cRNA  probe  and analyzed 
in dark-field, x8. 
but was present only 1-4 h after in vivo stimulation. A pos- 
sible reason is that in vivo T cells are activated almost simul- 
taneously and instantly in the intact, densely packed microen- 
vironment  by the superantigen that does not require processing 
and is rapidly deared from the body (25).  In vitro, T  cell 
activation probably requires  more time because of the need 
for establishing cell-cell contacts. A simultaneous activation 
is not possible, but the mitogen is present throughout the 
culture period and may activate T cells at different time points. 
Within the first hour, all four cytokine mRNAs had a very 
similar localization:  they were found in the PALS, the T cell 
areas of the spleen,  whereas they were undetectable in the 
B cell-containing follicles and in the red pulp signals. This 
pattern of the burstlike response to SEB of mRNA for IL-2, 
IFN-'y, and TNF-fl was unchanged in macrophage-depleted 
animals.  These  results  show  that  in  vivo,  the  decisive 
superantigen-presenting cells are not macrophages but are 
probably dendritic cells. In vitro, dendritic cells have been 
shown to be up to 50 times more potent than other APCs 
as stimulators for antigens (26)  and superantigens (27). 
After LPS administration, the mRNA for TNF-ct was still 
strongly induced in macrophage-depleted mice, but with a 
lower intensity and a different distribution pattern. Whereas 
in normal mice, LPS induced a strong and diffuse staining 
for TNF-ct mRNA, in macrophage-deplet~  mice this mRNA 
was induced in a dustered expression (Fig. 5 H), with a dis- 
tribution similar to the expression of the T cell-specific  mRNA 
(Fig. 5, B and F). Thus, in the depleted mice, nonphagocytic 
cells, presumably dendritic cells, are the responders to LPS. 
The restricted localization of the TNF-ct mRNA in macro- 
phage-depleted mice is in accordance with the demonstra- 
tion (17) that dendritic cells are present in the PALS of mouse 
spleen. 
After SEB injection, the TNF-ct mRNA behaved differ- 
ently  from  the  mRNAs  for  IL-2,  IFN-'y,  and  TNF-fl. 
Whereas the latter cytokine mRNAs were exclusively ex- 
pressed in the T cell areas, TNF-o~ mRNA changed its dis- 
tribution from the early clustering in the T  cell areas to a 
broadly distributed pattern in white and red pulp after 3 h, 
indicating that a second cell population started to express this 
mRNA. This pattern was similar to the distribution of TNF-tx 
mRNA in response to LPS in normal mice. A likely explana- 
tion is that the second phase is due to expression of TNF-oe 
mRNA in macrophages. This notion is supported by the 
finding that this hte phase  was  missing in macrophage-depleted 
animals.  In these animals,  TNF-ol is produced by T  cells, 
and, in the second phase, possibly by dendritic cells as well. 
Taken  together,  these  findings  indicate  that  the  early 
cytokine burst after SEB injection, including TNF-cx, is T 
cell derived. Thus, in the first 2 h, TNF-cx  mRNA is ex- 
pressed mainly in T  cells and in the second phase,  mainly 
in macrophages. The early peak of TNF activity in the serum 
and the delayed expression of TNF-/3 mRNA could indicate 
that most of the TNF protein is TNF-cx derived from the 
first phase, i.e., is produced by T cells. The complete sensi- 
tivity to CyA of all mRNAs suggests that the production 
of TNF-cx in the second phase by macrophages is T cell de- 
pendent. This would be in agreement with in vitro studies 
showing that a strong TNF-cx production is only seen when 
both T  cells and monocytes are incubated together (7). 
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